Medication info
Bonejoa Tablet (Ibandronic Acid Sodium Hydrate)

Bonejoa Tablet (Ibandronic Acid Sodium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
1 tablet/PTP
Approval status
Active

MFDS item code 201403255 · Approved 2014.07.18 · Insurance code 625200540

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month, in the morning with plenty of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium) : - This medicine must be swallowed with plenty of water (180~240ml) while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take a dose on the regularly scheduled day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet in the morning on the day after realizing that the dose was missed, and thereafter take 1 tablet each month on the previously scheduled day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled day, and thereafter continue taking 1 tablet each month on the previously scheduled day. - Do not take 2 tablets within the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or greater. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dose adjustment is necessary.
Child dose
Children and adolescents aged 18 years or younger: Efficacy and safety have not been studied.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis in postmenopausal women. Osteoporosis is a condition that weakens bones, making them more susceptible to fractures. Taking this medication helps increase bone strength and reduce the risk of fractures, thereby maintaining healthy bones and improving quality of life.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month, in the morning with plenty of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium) : - This medicine must be swallowed with plenty of water (180~240ml) while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take a dose on the regularly scheduled day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet in the morning on the day after realizing that the dose was missed, and thereafter take 1 tablet each month on the previously scheduled day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled day, and thereafter continue taking 1 tablet each month on the previously scheduled day. - Do not take 2 tablets within the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or greater. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dose adjustment is necessary.

Child dose

Children and adolescents aged 18 years or younger: Efficacy and safety have not been studied.

Precautions

This medication should not be used in certain patients. For example, those who are allergic to this medication or its ingredients, have untreated hypocalcemia, cannot sit upright or stand for at least 60 minutes, have esophageal dysfunction leading to difficulty swallowing food, or have lactose intolerance or related genetic disorders should not take this medication. Patients with severe renal impairment should use this medication cautiously. While taking this medication, side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headache, fatigue, muscle pain, joint pain, rash may occur. Some patients may experience influenza-like symptoms or gastrointestinal issues such as esophagitis and esophageal ulcers, so caution is advised. Since this medication can irritate the gastrointestinal mucosa, patients with upper gastrointestinal diseases such as gastritis, esophagitis, or ulcers must consult a doctor before taking it. If swallowing difficulty or chest pain occurs during treatment, stop taking the medication immediately and inform a healthcare professional. Additionally, taking this medication with calcium, milk, or antacids can interfere with absorption, so it is important not to eat food or take other medications for at least 1 hour after taking this medication. There have been reports of rare side effects such as osteonecrosis of the jaw or external auditory canal necrosis, so patients with cancer or poor oral hygiene should ideally receive a dental check-up before taking this medication. It is recommended to avoid dental treatment while on this medication. While treating osteoporosis, severe bone, joint, or muscle pain may occur, and should these symptoms arise, patients should consult with their healthcare provider. Additionally, atypical fractures of the femur or other bones can occur, so if there is pain in the thigh or groin, immediate evaluation is necessary. Women who are pregnant or breastfeeding should refrain from using this medication. Elderly patients do not require dosage adjustment, but safety and efficacy have not been established in children under 18 years of age. In case of overdose, gastrointestinal disturbances and hypocalcemia may occur, so caution is needed to avoid overdose. If an overdose is suspected, contact a healthcare professional immediately for appropriate action. Finally, this medication should be kept out of reach of children, and unused medications should be disposed of properly to prevent environmental harm.

Side effects

Dyspepsia, nausea, abdominal pain, diarrhea, distention, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, esophagitis, dizziness, low back pain, duodenitis, hypersensitivity reactions, angioedema, facial edema, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, exacerbation of asthma, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical subtrochanteric and diaphyseal femoral fractures, atypical fractures of the iliac bone, abnormal sensations in the eyes, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained at room temperature, between 1°C and 30°C. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

1 tablet/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.